261 related articles for article (PubMed ID: 16107719)
1. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.
Dawson JP; Berger MB; Lin CC; Schlessinger J; Lemmon MA; Ferguson KM
Mol Cell Biol; 2005 Sep; 25(17):7734-42. PubMed ID: 16107719
[TBL] [Abstract][Full Text] [Related]
2. Ligand-induced structural transitions in ErbB receptor extracellular domains.
Dawson JP; Bu Z; Lemmon MA
Structure; 2007 Aug; 15(8):942-54. PubMed ID: 17697999
[TBL] [Abstract][Full Text] [Related]
3. Activation of the epidermal growth factor receptor: a series of twists and turns.
Poger D; Mark AE
Biochemistry; 2014 Apr; 53(16):2710-21. PubMed ID: 24697572
[TBL] [Abstract][Full Text] [Related]
4. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
[TBL] [Abstract][Full Text] [Related]
5. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E
Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089
[TBL] [Abstract][Full Text] [Related]
6. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
[TBL] [Abstract][Full Text] [Related]
7. Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.
Bessman NJ; Bagchi A; Ferguson KM; Lemmon MA
Cell Rep; 2014 Nov; 9(4):1306-17. PubMed ID: 25453753
[TBL] [Abstract][Full Text] [Related]
8. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
Zhu L; Zhao L; Wu M; Chen Z; Li H
Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
[TBL] [Abstract][Full Text] [Related]
9. A structural perspective on the regulation of the epidermal growth factor receptor.
Kovacs E; Zorn JA; Huang Y; Barros T; Kuriyan J
Annu Rev Biochem; 2015; 84():739-64. PubMed ID: 25621509
[TBL] [Abstract][Full Text] [Related]
10. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
Walker F; Rothacker J; Henderson C; Nice EC; Catimel B; Zhang HH; Scott AM; Bailey MF; Orchard SG; Adams TE; Liu Z; Garrett TP; Clayton AH; Burgess AW
Growth Factors; 2012 Dec; 30(6):394-409. PubMed ID: 23163584
[TBL] [Abstract][Full Text] [Related]
12. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
[TBL] [Abstract][Full Text] [Related]
13. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
[TBL] [Abstract][Full Text] [Related]
14. Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study.
Mustafa M; Mirza A; Kannan N
Proteins; 2011 Jan; 79(1):99-114. PubMed ID: 20938978
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.
Li S; Schmitz KR; Jeffrey PD; Wiltzius JJ; Kussie P; Ferguson KM
Cancer Cell; 2005 Apr; 7(4):301-11. PubMed ID: 15837620
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
[TBL] [Abstract][Full Text] [Related]
17. Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation.
Papakyriakou A; Vourloumis D; Tzortzatou-Stathopoulou F; Karpusas M
Proteins; 2009 Aug; 76(2):375-86. PubMed ID: 19173306
[TBL] [Abstract][Full Text] [Related]
18. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
19. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
Stanley AM; Fleming KG
J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
